Gastroduodenal response to low-dose glucagon.

Area of Science:

• Radiology
• Gastroenterology

Background:

• The double-contrast upper gastrointestinal examination is a key diagnostic tool.
• Glucagon is often used to reduce gastrointestinal motility during such examinations.

Purpose of the Study:

• To evaluate the efficacy of glucagon in improving the quality of double-contrast upper gastrointestinal examinations.
• To determine the optimal glucagon dosage for diagnostic imaging.

Main Methods:

• A prospective, double-blind clinical study involving 240 patients.
• Administration of glucagon in varying doses (0.025-0.125 mg) to assess its effects on gastric and duodenal distension, coating, and pyloric function.

Main Results:

• Glucagon diminished gastric motility but did not improve gastric distension or coating.
• Duodenal distension and coating were significantly enhanced.
• Pyloric response varied; glucagon did not prevent barium spillage but delayed gastric emptying in patients with a competent pylorus.
• Increased spontaneous gastroesophageal reflux was observed.
• A threshold dose of 0.05 mg glucagon was identified for observable changes.

Conclusions:

• Glucagon primarily benefits duodenal visualization in upper GI studies.
• It offers no significant advantage for stomach or pyloric imaging.
• Dose-dependent effects are crucial, with 0.05 mg being a key threshold.